Literature DB >> 19812386

Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.

Thomas H Sisson1, Mai-Huong Nguyen, Bi Yu, Margaret L Novak, Richard H Simon, Timothy J Koh.   

Abstract

The plasminogen system plays a crucial role in the repair of a variety of tissues, including skeletal muscle. We hypothesized that urokinase-type plasminogen activator (uPA) promotes muscle regeneration by activating hepatocyte growth factor (HGF), which, in turn, stimulates proliferation of myoblasts required for regeneration. In our studies, levels of active HGF and phosphorylation of the HGF receptor c-met were increased after muscle injury in wild-type mice. Compared with wild-type animals, mice deficient in uPA (uPA(-/-)) had markedly reduced HGF levels and c-met activation after muscle damage. This reduced HGF activity in uPA(-/-) animals was associated with decreased cell proliferation, myoblast accumulation, and new muscle fiber formation. On the other hand, HGF activity was enhanced at early time points in PAI-1(-/-) mice compared with wild-type mice and the PAI-1(-/-) animals exhibited accelerated muscle fiber regeneration. Furthermore, administration of exogenous uPA rescued HGF levels and muscle regeneration in uPA(-/-) mice, and an HGF-blocking antibody reduced HGF activity and muscle regeneration in wild-type mice. We also found that uPA promotes myoblast proliferation in vitro through its proteolytic activity, and this process was inhibited by an HGF-blocking antibody. Together, our findings demonstrate that uPA promotes muscle regeneration through HGF activation and subsequent myoblast proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812386      PMCID: PMC2788978          DOI: 10.1182/blood-2008-12-196212

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Active hepatocyte growth factor is present in skeletal muscle extracellular matrix.

Authors:  Ryuichi Tatsumi; Ronald E Allen
Journal:  Muscle Nerve       Date:  2004-11       Impact factor: 3.217

2.  Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages.

Authors:  H A Chapman; J J Reilly; L Kobzik
Journal:  Am Rev Respir Dis       Date:  1988-02

3.  Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.

Authors:  J D Vassalli; J Hamilton; E Reich
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

4.  Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy.

Authors:  Guoqiang Zhang; Heungsoo Kim; Xiaohe Cai; Jesús M López-Guisa; Charles E Alpers; Youhua Liu; Peter Carmeliet; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

5.  Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.

Authors:  Orna Halevy; Lewis C Cantley
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905

6.  Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle.

Authors:  E Jennische; S Ekberg; G L Matejka
Journal:  Am J Physiol       Date:  1993-07

7.  Domain-dependent action of urokinase on smooth muscle cell responses.

Authors:  William J Tanski; Allison J Fegley; Elisa Roztocil; Mark G Davies
Journal:  J Vasc Surg       Date:  2004-01       Impact factor: 4.268

8.  Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis.

Authors:  Y Matsuno; H Iwata; Y Umeda; H Takagi; Y Mori; A Kosugi; K Matsumoto; T Nakamura; H Hirose
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

9.  The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.

Authors:  Noboru Hattori; Shinya Mizuno; Yuka Yoshida; Kazuo Chin; Michiaki Mishima; Thomas H Sisson; Richard H Simon; Toshikazu Nakamura; Masayuki Miyake
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

10.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

Authors:  L Naldini; L Tamagnone; E Vigna; M Sachs; G Hartmann; W Birchmeier; Y Daikuhara; H Tsubouchi; F Blasi; P M Comoglio
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  27 in total

Review 1.  Phenotypic transitions of macrophages orchestrate tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  Am J Pathol       Date:  2013-09-30       Impact factor: 4.307

2.  The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.

Authors:  Anthony J Courey; Jeffrey C Horowitz; Kevin K Kim; Timothy J Koh; Margaret L Novak; Natalya Subbotina; Mark Warnock; Bing Xue; Andrew K Cunningham; Yujing Lin; Monica P Goldklang; Richard H Simon; Daniel A Lawrence; Thomas H Sisson
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

3.  Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration.

Authors:  Margaret L Novak; Scott C Bryer; Ming Cheng; Mai-Huong Nguyen; Kevin L Conley; Andrew K Cunningham; Bing Xue; Thomas H Sisson; Jae-Sung You; Troy A Hornberger; Timothy J Koh
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

Review 4.  Biomaterial-based delivery for skeletal muscle repair.

Authors:  Christine A Cezar; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2014-09-28       Impact factor: 15.470

Review 5.  Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.

Authors:  Youngjoo Kwon; Andrew K Godwin
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

Review 6.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01

7.  Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Hong-Long Ji; Pierre F Neuenschwander; Vijay Boggaram; Gilbert F Morris; Jian Fu; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2013-05-08       Impact factor: 4.307

8.  Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.

Authors:  Ariel Diaz; Paola Merino; Patrick McCann; Manuel A Yepes; Laura G Quiceno; Enrique Torre; Amelia Tomkins; Xiaodong Zhang; Chadwick M Hales; Frank C Tong; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

9.  CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34.

Authors:  Fumihiro Yamane; Yumiko Nishikawa; Kazue Matsui; Miki Asakura; Eriko Iwasaki; Koji Watanabe; Hikaru Tanimoto; Hiroki Sano; Yuki Fujiwara; E Richard Stanley; Naoki Kanayama; Neil A Mabbott; Masaki Magari; Hitoshi Ohmori
Journal:  J Leukoc Biol       Date:  2013-09-19       Impact factor: 4.962

Review 10.  The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.

Authors:  Toshikazu Nakamura; Shinya Mizuno
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.